Beken Bio

San Diego, United States

Beken Bio develops surgical fluid tests that help diagnose cancer.

$750K raised

Dec 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Beken Bio raised?

Beken Bio has raised $750K in total funding. The most recent round was Seed. The last funding was announced in December 2025.

Who are Beken Bio's investors?

Beken Bio's investors include Boot64 Ventures, Curebound, Tulane Ventures, New Orleans BioFund, 1834 Ventures.

Where is Beken Bio headquartered?

Beken Bio is headquartered in San Diego, United States.

What does Beken Bio do?

Beken Bio develops surgical fluid tests that help diagnose cancer.

What stage is Beken Bio at?

Beken Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 10, 2025.

MLA

"Beken Bio — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/beken-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). Beken Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/beken-bio

Wikipedia (cite web)

{{cite web |title=Beken Bio — Funding & Investors |url=https://www.vcbacked.co/company/beken-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 10, 2025.